scispace - formally typeset
P

Pavel Hobza

Researcher at Academy of Sciences of the Czech Republic

Publications -  567
Citations -  51511

Pavel Hobza is an academic researcher from Academy of Sciences of the Czech Republic. The author has contributed to research in topics: Ab initio & Hydrogen bond. The author has an hindex of 107, co-authored 564 publications receiving 48080 citations. Previous affiliations of Pavel Hobza include Czechoslovak Academy of Sciences & Fritz Haber Institute of the Max Planck Society.

Papers
More filters
Journal ArticleDOI

SQM/COSMO Scoring Function: Reliable Quantum-Mechanical Tool for Sampling and Ranking in Structure-Based Drug Design.

TL;DR: The experience gained in its application for activity ranking of ligands binding to tens of protein targets resulted in setting up a faster SQM/COSMO scoring approach, which outperforms standard scoring methods in native pose identification for two dozen protein targets with ten thousand poses.
Journal ArticleDOI

Theoretical insight into the stabilization of triazole fungicides via their interactions with dications

TL;DR: In this article, the problem of triazole-fungicide complexation with dications is demonstrated on the case of zinc and cadmium ions (M) using electrospray ionization mass spectrometry and quantum mechanical DFT-based computations.
Journal ArticleDOI

S⋯N chalcogen bonded complexes of carbon disulfide with diazines. Theoretical study

TL;DR: In this paper, a density functional BLYP-D3 and ab initio CCSD(T) methods were used to study carbon disulfide complexes with diazine (pyridazine, pyrimidine or pyrazine).
Journal ArticleDOI

The Existence of a N→C Dative Bond in the C60–Piperidine Complex

TL;DR: The results of thermodynamics calculations, molecular dynamics simulations and NMR and FT-IR spectroscopies explain the specific interactions between C 60 and piperidine, bringing a new insight into their controllable organic functionalization.
Journal ArticleDOI

Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles.

TL;DR: The structural basis for the interaction of roscovitine and analogues containing 13 different bioisosteric central heterocycles with the enzyme cyclin-dependent kinase 2 (CDK2) is elucidated and the contributions of the scaffolds and the individual substituents, quantified and evaluated in relation to conformations of optimized protein-inhibitor complexes, are found not to be simply additive.